Home LiteratureArticle Details
PMID: 2171222 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Isolation of a viable herpesvirus (pseudorabies virus) mutant specifically lacking all four known nonessential glycoproteins.

Virology ·Vol. 179 ·No. 1 ·1990-11-00 ·Pages 498-503

Mettenleiter TC, Kern H, Rauh I

Abstract

Recently we described the isolation and characterization of a pseudorabies virus (PrV) mutant lacking the nonessential glycoproteins gI, gp63, and gIII. Using insertional mutagenesis with a functional gX-beta-galactosidase fusion gene we describe here the isolation of a PrV mutant specifically lacking all four known nonessential glycoproteins, gI, gp63, gIII, and gX. The quadruple mutant did not show any significant alterations in the vitro growth characteristics compared to its triple mutant parent. These results prove that PrV nonessential glycoproteins are dispensable for viral replication in cell culture altogether.

MeSH Terms
Animals Blotting, Southern Cell Line Chromosome Deletion DNA, Viral/genetics,isolation & purification Genes, Viral Glycoproteins/genetics,isolation & purification Herpesvirus 1, Suid/genetics Molecular Weight Mutation Protein Biosynthesis RNA, Viral/genetics Restriction Mapping Vero Cells Viral Plaque Assay Viral Proteins/genetics,isolation & purification
Chemicals
DNA, Viral Glycoproteins RNA, Viral Viral Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Mettenleiter T C
Federal Research Centre for Virus Diseases of Animals, Tübingen, Federal Republic of Germany.
Kern H
Rauh I
Article Info
Journal
Virology
Abbr.
Virology
ISSN
0042-6822
Published
1990-11-00
Pages
498-503
Language
English
Region
United States
NLM ID
0110674
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com